Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Carcinogenesis|July 1, 1995
Effects of low doses of N-nitrosomorpholine on the development of early stages of hepatocarcinogenesisH Enzmann, H Zerban, A Kopp-Schneider, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|July 27, 2010
Carcinogen-induced Mitochondrial DNA Damage in the In Ovo ModelA Witt, H J Ahr, S Brendler-Schwaab, et al.
Laryngo- Rhino- Otologie|June 1, 1992
[Ozena and allergic rhinitis in ichthyosis vulgaris]C Reisser, H Enzmann, S Günzel, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|October 15, 1998
Short- and intermediate-term carcinogenicity testing--a review. Part 1: the prototypes mouse skin tumour assay and rat liver focus assayH Enzmann, E Bomhard, M Iatropoulos, et al.
ESMO Open|March 18, 2021
The European Medicines Agency review of entrectinib for the treatment of adult or paediatric patients with solid tumours who have a neurotrophic tyrosine receptor kinase gene fusions and adult patients with non-small-cell lung cancer harbouring ROS1 rearrangementsJ Delgado, E Pean, D Melchiorri, et al.
Cardiovascular Drugs and Therapy|July 4, 1998
Calcium channel blockers and the risk of cancer: a preclinical assessmentH J Ahr, E Bomhard, H Enzmann, et al.
ESMO Open|March 1, 2021
The EMA review of trastuzumab emtansine (T-DM1) for the adjuvant treatment of adult patients with HER2-positive early breast cancerJ Delgado, C Vleminckx, S Sarac, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 7, 2010
Characterization of proliferative effects of insulin, insulin analogues and insulin-like growth factor-1 (IGF-1) in human lung fibroblastsM Warnken, U Reitzenstein, A Sommer, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|October 15, 1998
Short- and intermediate-term carcinogenicity testing--a review. Part 2: available experimental modelsH Enzmann, M Iatropoulos, K D Brunnemann, et al.
ESMO Open|January 10, 2021
The EMA assessment of encorafenib in combination with cetuximab for the treatment of adult patients with metastatic colorectal carcinoma harbouring the BRAFV600E mutation who have received prior therapyA Trullas, J Delgado, J Koenig, et al.
Pageof 7